approved on a humanitarian device exemption) can be used as treatment
Zepbound should be discontinued if pregnancy is recognized
This could include reading, light stretching, or practicing relaxation techniques like deep breathing
However, despite these limitations, the present study suggests that the benefits of GLP-1RAs may extend beyond their established use in T2D and clinically obese communities, supporting further evaluation of these agents as adjunctive therapy for those who have spent a lifetime managing T1D
Dams JK, Eiken HG, Oie E, Bjerkeli V, Yndestad A, Ueland T, Tonnessen T, Geiran OR, Aass H, Simonsen S, Christensen G, Froland SS, Attramadal H, Gullestad L, Aukrust P
3.2 mg (10 units) daily for the activation phase (weeks 14)